190 related articles for article (PubMed ID: 35514958)
1. Multi-Platform Omics Analysis Reveals Molecular Signatures for Pathogenesis and Activity of Systemic Lupus Erythematosus.
Huang X; Luu LDW; Jia N; Zhu J; Fu J; Xiao F; Liu C; Li S; Shu G; Hou J; Kang M; Zhang D; Xu Y; Wang Y; Cui X; Lai J; Li J; Tai J
Front Immunol; 2022; 13():833699. PubMed ID: 35514958
[TBL] [Abstract][Full Text] [Related]
2. Advances in applying of multi-omics approaches in the research of systemic lupus erythematosus.
Song W; Tang D; Chen D; Zheng F; Huang S; Xu Y; Yu H; He J; Hong X; Yin L; Liu D; Dai W; Dai Y
Int Rev Immunol; 2020; 39(4):163-173. PubMed ID: 32138562
[TBL] [Abstract][Full Text] [Related]
3. The applied basic research of systemic lupus erythematosus based on the biological omics.
Sui W; Hou X; Che W; Yang M; Dai Y
Genes Immun; 2013 Apr; 14(3):133-46. PubMed ID: 23446742
[TBL] [Abstract][Full Text] [Related]
4. TMT-based quantitative proteomics analysis and potential serum protein biomarkers for systemic lupus erythematosus.
Zhou G; Wei P; Lan J; He Q; Guo F; Guo Y; Gu W; Xu T; Liu S
Clin Chim Acta; 2022 Sep; 534():43-49. PubMed ID: 35810799
[TBL] [Abstract][Full Text] [Related]
5. Integration of metabolomics and lipidomics reveals serum biomarkers for systemic lupus erythematosus with different organs involvement.
Zhang W; Zhao H; Du P; Cui H; Lu S; Xiang Z; Lu Q; Jia S; Zhao M
Clin Immunol; 2022 Aug; 241():109057. PubMed ID: 35667550
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic profiling reveals serum L-pyroglutamic acid as a potential diagnostic biomarker for systemic lupus erythematosus.
Zhang Q; Li X; Yin X; Wang H; Fu C; Wang H; Li K; Li Y; Zhang X; Liang H; Li K; Li H; Qiu Y
Rheumatology (Oxford); 2021 Feb; 60(2):598-606. PubMed ID: 32259244
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the free fatty acid metabolome in the plasma of patients with systemic lupus erythematosus and fever.
Shin TH; Kim HA; Jung JY; Baek WY; Lee HS; Park HJ; Min J; Paik MJ; Lee G; Suh CH
Metabolomics; 2017 Dec; 14(1):14. PubMed ID: 30830319
[TBL] [Abstract][Full Text] [Related]
8. Coagulation cascade and complement system in systemic lupus erythematosus.
Liang Y; Xie SB; Wu CH; Hu Y; Zhang Q; Li S; Fan YG; Leng RX; Pan HF; Xiong HB; Ye DQ
Oncotarget; 2018 Mar; 9(19):14862-14881. PubMed ID: 29599912
[TBL] [Abstract][Full Text] [Related]
9. Urinary metabolomic study of systemic lupus erythematosus based on gas chromatography/mass spectrometry.
Yan B; Huang J; Dong F; Yang L; Huang C; Gao M; Shi A; Zha W; Shi L; Hu X
Biomed Chromatogr; 2016 Nov; 30(11):1877-1881. PubMed ID: 27061577
[TBL] [Abstract][Full Text] [Related]
10. Differential expressions of plasma proteins in systemic lupus erythematosus patients identified by proteomic analysis.
Madda R; Lin SC; Sun WH; Huang SL
J Microbiol Immunol Infect; 2019 Oct; 52(5):816-826. PubMed ID: 30170966
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics identification of key candidate genes and pathways associated with systemic lupus erythematosus.
Yang F; Zhai Z; Luo X; Luo G; Zhuang L; Zhang Y; Li Y; Sun E; He Y
Clin Rheumatol; 2020 Feb; 39(2):425-434. PubMed ID: 31673979
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic tests in systemic lupus erythematosus.
Vasquez-Canizares N; Wahezi D; Putterman C
Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):351-363. PubMed ID: 29224677
[TBL] [Abstract][Full Text] [Related]
13. Circulating microparticles in systemic Lupus Erythematosus.
Nielsen CT
Dan Med J; 2012 Nov; 59(11):B4548. PubMed ID: 23171755
[TBL] [Abstract][Full Text] [Related]
14. Fecal Metabolites Were Altered, Identified as Biomarkers and Correlated With Disease Activity in Patients With Systemic Lupus Erythematosus in a GC-MS-Based Metabolomics Study.
Yan R; Jiang H; Gu S; Feng N; Zhang N; Lv L; Liu F
Front Immunol; 2020; 11():2138. PubMed ID: 33013903
[TBL] [Abstract][Full Text] [Related]
15. Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.
Idborg H; Zandian A; Sandberg AS; Nilsson B; Elvin K; Truedsson L; Sohrabian A; Rönnelid J; Mo J; Grosso G; Kvarnström M; Gunnarsson I; Lehtiö J; Nilsson P; Svenungsson E; Jakobsson PJ
Arthritis Res Ther; 2019 Feb; 21(1):62. PubMed ID: 30777133
[TBL] [Abstract][Full Text] [Related]
16. Hsa_circ_0000479 as a Novel Diagnostic Biomarker of Systemic Lupus Erythematosus.
Guo G; Wang H; Ye L; Shi X; Yan K; Lin K; Huang Q; Li B; Lin Q; Zhu L; Xue X; Zhang H
Front Immunol; 2019; 10():2281. PubMed ID: 31608065
[No Abstract] [Full Text] [Related]
17. Revealing the Immune Heterogeneity between Systemic Lupus Erythematosus and Rheumatoid Arthritis Based on Multi-Omics Data Analysis.
Zhang Y; Lee TY
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563556
[TBL] [Abstract][Full Text] [Related]
18. Chemokine CXCL1 as a potential marker of disease activity in systemic lupus erythematosus.
Zeng Y; Lin Q; Yu L; Wang X; Lin Y; Zhang Y; Yan S; Lu X; Li Y; Li W; Xiao Y
BMC Immunol; 2021 Dec; 22(1):82. PubMed ID: 34961474
[TBL] [Abstract][Full Text] [Related]
19. Assessment of a high-avidity IgG ANAs for the diagnosis and activity prediction of systemic lupus erythematosus.
Zeng Y; Lin Y; Wang X; Zhang Y; Peng F; Wang J; Jiang L; Liang S; Xiao Y
Clin Rheumatol; 2020 Sep; 39(9):2619-2629. PubMed ID: 32189150
[TBL] [Abstract][Full Text] [Related]
20. Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity.
Kim AHJ; Strand V; Sen DP; Fu Q; Mathis NL; Schmidt MJ; Bruchas RR; Staten NR; Olson PK; Stiening CM; Atkinson JP
Arthritis Rheumatol; 2019 Mar; 71(3):420-430. PubMed ID: 30294950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
